Østerdal ML - Search Results

1

Biological Effects of Ingenol Mebutate Gel in Moderate to Severe Actinic Fields Assessed by Reflectance Confocal Microscopy: A Phase I Study.

Ulrich M, Lange-Asschenfeldt S, Skak K, Skov T, Østerdal ML, Röwert-Huber HJ, Zibert JR, Stockfleth E. Ulrich M, et al. Among authors: osterdal ml. J Drugs Dermatol. 2016 Oct 1;15(10):1181-1189. J Drugs Dermatol. 2016. PMID: 27741334 Clinical Trial.

2

Efficacy and safety of ingenol mebutate gel in field treatment of actinic keratosis on full face, balding scalp, or approximately 250 cm² on the chest: A phase 3 randomized controlled trial.

Hanke CW, Albrecht L, Skov T, Larsson T, Østerdal ML, Spelman L. Hanke CW, et al. Among authors: osterdal ml. J Am Acad Dermatol. 2020 Mar;82(3):642-650. doi: 10.1016/j.jaad.2019.07.083. Epub 2019 Jul 30. J Am Acad Dermatol. 2020. PMID: 31374304 Clinical Trial.

3

Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp.

Stockfleth E, Harwood CA, Serra-Guillén C, Larsson T, Østerdal ML, Skov T. Stockfleth E, et al. Among authors: osterdal ml. Br J Dermatol. 2018 Feb;178(2):433-442. doi: 10.1111/bjd.16048. Epub 2018 Jan 15. Br J Dermatol. 2018. PMID: 29030864 Clinical Trial.

4

Response to 'Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp': reply from the authors.

Stockfleth E, Harwood CA, Serra-Guillén C, Larsson T, Østerdal ML, Skov T. Stockfleth E, et al. Among authors: osterdal ml. Br J Dermatol. 2018 Mar;178(3):813-814. doi: 10.1111/bjd.16225. Epub 2018 Feb 7. Br J Dermatol. 2018. PMID: 29206275 No abstract available.

5

A seamless phase I/II dose-finding trial assessing ingenol disoxate (LEO 43204) for field treatment of actinic keratosis on the scalp.

Weiss J, Ulrich M, Bukhalo M, Østerdal ML, Bang B, Hanke CW. Weiss J, et al. Among authors: osterdal ml. Br J Dermatol. 2017 Jun;176(6):1456-1464. doi: 10.1111/bjd.15304. Epub 2017 Apr 25. Br J Dermatol. 2017. PMID: 28078678 Clinical Trial.

6

Efficacy and safety of follow-up field treatment of actinic keratosis with ingenol mebutate 0·015% gel: a randomized, controlled 12-month study.

Garbe C, Basset-Seguin N, Poulin Y, Larsson T, Østerdal ML, Venkata R, Lear JT. Garbe C, et al. Among authors: osterdal ml. Br J Dermatol. 2016 Mar;174(3):505-13. doi: 10.1111/bjd.14222. Epub 2016 Jan 9. Br J Dermatol. 2016. PMID: 26471889 Clinical Trial.

7

A randomized, phase IIa exploratory trial to assess the safety and preliminary efficacy of LEO 43204 in patients with actinic keratosis.

Sinnya S, Tan JM, Prow TW, Primiero C, McEniery E, Selmer J, Østerdal ML, Soyer HP. Sinnya S, et al. Among authors: osterdal ml. Br J Dermatol. 2016 Feb;174(2):305-11. doi: 10.1111/bjd.14245. Epub 2016 Jan 9. Br J Dermatol. 2016. PMID: 26499175 Clinical Trial.

8

Efficacy and Safety of Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam in Patients With Psoriasis Vulgaris--a Randomized Phase III Study (PSO-FAST).

Leonardi C, Bagel J, Yamauchi P, Pariser D, Xu Z, Olesen M, Østerdal ML, Stein Gold L. Leonardi C, et al. Among authors: osterdal ml. J Drugs Dermatol. 2015 Dec;14(12):1468-77. J Drugs Dermatol. 2015. PMID: 26659941 Clinical Trial.

9

The Aerosol Foam Formulation of the Fixed Combination Calcipotriene Plus Betamethasone Dipropionate Improves the Health-Related Quality of Life in Patients With Psoriasis Vulgaris: Results from the Randomized PSO-FAST Study.

Leonardi C, Bagel J, Yamauchi P, Pariser D, Xu Z, Moller A, Osterdal ML, Stein Gold L. Leonardi C, et al. Among authors: osterdal ml. J Drugs Dermatol. 2016 Aug 1;15(8):981-7. J Drugs Dermatol. 2016. PMID: 27537999 Clinical Trial.

10

Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2).

Wollenberg A, Blauvelt A, Guttman-Yassky E, Worm M, Lynde C, Lacour JP, Spelman L, Katoh N, Saeki H, Poulin Y, Lesiak A, Kircik L, Cho SH, Herranz P, Cork MJ, Peris K, Steffensen LA, Bang B, Kuznetsova A, Jensen TN, Østerdal ML, Simpson EL; ECZTRA 1 and ECZTRA 2 study investigators. Wollenberg A, et al. Among authors: osterdal ml. Br J Dermatol. 2021 Mar;184(3):437-449. doi: 10.1111/bjd.19574. Epub 2020 Dec 30. Br J Dermatol. 2021. PMID: 33000465 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page